322 related articles for article (PubMed ID: 37447385)
41. Lupeol triggers oxidative stress, ferroptosis, apoptosis and restrains inflammation in nasopharyngeal carcinoma via AMPK/NF-κB pathway.
Zhou JC; Wu B; Zhang JJ; Zhang W
Immunopharmacol Immunotoxicol; 2022 Aug; 44(4):621-631. PubMed ID: 35486494
[TBL] [Abstract][Full Text] [Related]
42. A dual activity of ROS and oxidative stress on adult neurogenesis and Alzheimer's disease.
Taupin P
Cent Nerv Syst Agents Med Chem; 2010 Mar; 10(1):16-21. PubMed ID: 20236039
[TBL] [Abstract][Full Text] [Related]
43. Redefining oxidative stress in Alzheimer's disease: Targeting platelet reactive oxygen species for novel therapeutic options.
Beura SK; Dhapola R; Panigrahi AR; Yadav P; Reddy DH; Singh SK
Life Sci; 2022 Oct; 306():120855. PubMed ID: 35926591
[TBL] [Abstract][Full Text] [Related]
44. Beneficial health effects of lupeol triterpene: a review of preclinical studies.
Siddique HR; Saleem M
Life Sci; 2011 Feb; 88(7-8):285-93. PubMed ID: 21118697
[TBL] [Abstract][Full Text] [Related]
45. Lupeol, a triterpene, inhibits early responses of tumor promotion induced by benzoyl peroxide in murine skin.
Saleem M; Alam A; Arifin S; Shah MS; Ahmed B; Sultana S
Pharmacol Res; 2001 Feb; 43(2):127-34. PubMed ID: 11243713
[TBL] [Abstract][Full Text] [Related]
46. Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease.
Tönnies E; Trushina E
J Alzheimers Dis; 2017; 57(4):1105-1121. PubMed ID: 28059794
[TBL] [Abstract][Full Text] [Related]
47. Natural Antioxidants: An Effective Strategy for the Treatment of Alzheimer's Disease at the Early Stage.
Wang Y; Huang Y; Ma A; You J; Miao J; Li J
J Agric Food Chem; 2024 May; 72(21):11854-11870. PubMed ID: 38743017
[TBL] [Abstract][Full Text] [Related]
48. Potential for therapeutic use of hydrogen sulfide in oxidative stress-induced neurodegenerative diseases.
Tabassum R; Jeong NY
Int J Med Sci; 2019; 16(10):1386-1396. PubMed ID: 31692944
[TBL] [Abstract][Full Text] [Related]
49. Lupeol protects against acetaminophen-induced oxidative stress and cell death in rat primary hepatocytes.
Kumari A; Kakkar P
Food Chem Toxicol; 2012 May; 50(5):1781-9. PubMed ID: 22406326
[TBL] [Abstract][Full Text] [Related]
50. Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?
de Vries HE; Witte M; Hondius D; Rozemuller AJ; Drukarch B; Hoozemans J; van Horssen J
Free Radic Biol Med; 2008 Nov; 45(10):1375-83. PubMed ID: 18824091
[TBL] [Abstract][Full Text] [Related]
51. Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer's disease.
Polidori MC; Griffiths HR; Mariani E; Mecocci P
Amino Acids; 2007; 32(4):553-9. PubMed ID: 17273806
[TBL] [Abstract][Full Text] [Related]
52. Lupeol inhibits LPS-induced neuroinflammation in cerebellar cultures and induces neuroprotection associated to the modulation of astrocyte response and expression of neurotrophic and inflammatory factors.
Oliveira-Junior MS; Pereira EP; de Amorim VCM; Reis LTC; do Nascimento RP; da Silva VDA; Costa SL
Int Immunopharmacol; 2019 May; 70():302-312. PubMed ID: 30852286
[TBL] [Abstract][Full Text] [Related]
53. The influence of common free radicals and antioxidants on development of Alzheimer's Disease.
Wojtunik-Kulesza KA; Oniszczuk A; Oniszczuk T; Waksmundzka-Hajnos M
Biomed Pharmacother; 2016 Mar; 78():39-49. PubMed ID: 26898423
[TBL] [Abstract][Full Text] [Related]
54. Oxidative stress, antioxidants and neurodegenerative diseases.
Casetta I; Govoni V; Granieri E
Curr Pharm Des; 2005; 11(16):2033-52. PubMed ID: 15974957
[TBL] [Abstract][Full Text] [Related]
55. Management of oxidative stress and other pathologies in Alzheimer's disease.
Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
[TBL] [Abstract][Full Text] [Related]
56. Lupeol against high-glucose-induced apoptosis via enhancing the anti-oxidative stress in rabbit nucleus pulposus cells.
Guo MB; Wang DC; Liu HF; Chen LW; Wei JW; Lin Y; Xue H
Eur Spine J; 2018 Oct; 27(10):2609-2620. PubMed ID: 30008063
[TBL] [Abstract][Full Text] [Related]
57. Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of Lupeol mode of action.
Esposito F; Mandrone M; Del Vecchio C; Carli I; Distinto S; Corona A; Lianza M; Piano D; Tacchini M; Maccioni E; Cottiglia F; Saccon E; Poli F; Parolin C; Tramontano E
Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28637198
[TBL] [Abstract][Full Text] [Related]
58. Growth inhibition and apoptosis induced by lupeol, a dietary triterpene, in human hepatocellular carcinoma cells.
He Y; Liu F; Zhang L; Wu Y; Hu B; Zhang Y; Li Y; Liu H
Biol Pharm Bull; 2011; 34(4):517-22. PubMed ID: 21467639
[TBL] [Abstract][Full Text] [Related]
59. Advances in Antioxidant Nanomedicines for Imaging and Therapy of Alzheimer's Disease.
Hasan I; Guo B; Zhang J; Chang C
Antioxid Redox Signal; 2024 May; 40(13-15):863-888. PubMed ID: 36070437
[No Abstract] [Full Text] [Related]
60. In vivo ROS production and use of oxidative stress-derived biomarkers to detect the onset of diseases such as Alzheimer's disease, Parkinson's disease, and diabetes.
Umeno A; Biju V; Yoshida Y
Free Radic Res; 2017 Apr; 51(4):413-427. PubMed ID: 28372523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
